Kercheville Advisors, LLC Crispr Therapeutics Ag Transaction History

Kercheville Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 29, 2022	SELL	$53.19 - $79.24 $278,981 - $415,613	-5,245 Closed	0 $0
Q4 2021 Jan 26, 2022	SELL	$70.09 - $111.29 $72,893 - $115,741	-1,040 Reduced 16.55%	5,245 $397,000
Q3 2021 Nov 15, 2021	BUY	$110.2 - $156.64 $75,487 - $107,298	685 Added 12.23%	6,285 $703,000
Q2 2021 Nov 15, 2021	BUY	$100.84 - $161.89 $9,579 - $15,379	95 Added 1.73%	5,600 $907,000
Q1 2021 Nov 15, 2021	SELL	$110.72 - $210.04 $1,660 - $3,150	-15 Reduced 0.27%	5,505 $663,000
Q4 2020 Nov 12, 2021	BUY	$79.67 - $173.23 $439,778 - $956,229	5,520 New	5,520 $848,000

488

57.8M

1.09M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.21B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Kercheville Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Kercheville Advisors, LLC with notifications on news.